enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.76
+0.16 (2.11%)
Apr 15, 2026, 4:00 PM EDT - Market closed
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $519.84 million as of April 15, 2026. Its market cap has increased by 127.62% in one year.
Market Cap
519.84M
Enterprise Value
277.35M
1-Year Change
127.62%
Ranking
Category
Stock Price
$7.76
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has increased from $155.91M to $519.84M, an increase of 233.42%. That is a compound annual growth rate of 33.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 519.84M | -14.06% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 512.10M |
| AgomAb Therapeutics NV | 511.74M |
| Fulcrum Therapeutics | 510.16M |
| Verastem | 501.54M |
| Larimar Therapeutics | 500.20M |
| ADC Therapeutics | 493.57M |
| Invivyd | 487.84M |
| Entrada Therapeutics | 487.44M |